Discover
ACHV
Achieve Life Sciences, Inc.
7.94
1 x 7.90
2 x 10.08
bid
ask
-
0.16
1.98%
2 @ 04:21 AM
8.00 +0.06 (0.76%)
| Ytd | 59.76% | |
| 1y | 166.44% |
7.82
day range
8.14
2.62
52 week range
8.61
| Open | 8.07 | Prev Close | 8.10 | Low | 7.82 | High | 8.14 | Mkt Cap | 817.05M |
| Vol | 1.06M | Avg Vol | 1.79M | EPS | -1.66 | P/E | N/A | Forward P/E | -3.30 |
| Beta | 1.58 | Short Ratio | 23.98 | Inst. Own | 59.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 6.67 | 200-d Avg | 5.07 | 1yr Est | 16.44 |
| Income Statement | |||
| Operating Expenses | 18.39M | ||
| Research and Development Expense | 3.81M | ||
| Selling, General and Administrative Expense | 14.58M | ||
| Operating Income | -18.39M | ||
| Interest Expense | 277.00K | ||
| Net Income | -74.77M | ||
| Net Income Common Stock | -74.77M | ||
| Net Income Common Stock (USD) | -74.77M | ||
| Consolidated Income | -74.77M | ||
| Earnings per Basic Share | -0.80 | ||
| Earnings per Basic Share (USD) | -0.80 | ||
| Earnings per Diluted Share | -0.80 | ||
| Earning Before Interest & Taxes (EBIT) | -74.49M | ||
| Earning Before Interest & Taxes (USD) | -74.49M | ||
| Weighted Average Shares | 93.51M | ||
| Weighted Average Shares Diluted | 93.51M | ||
| Balance Sheet | |||
| Cash and Equivalents | 47.96M | ||
| Cash and Equivalents (USD) | 47.96M | ||
| Investments | 139.35M | ||
| Investments Current | 139.35M | ||
| Current Assets | 188.29M | ||
| Property, Plant & Equipment Net | 34.00K | ||
| Total Assets | 190.44M | ||
| Debt Current | 7.49M | ||
| Total Debt | 14.95M | ||
| Current Liabilities | 197.66M | ||
| Debt Non-Current | 7.46M | ||
| Total Liabilities | 205.12M | ||
| Accumulated Retained Earnings (Deficit) | -345.16M | ||
| Accumulated Other Comprehensive Income | -88.00K | ||
| Shareholders Equity | -14.68M | ||
| Shareholders Equity (USD) | -14.68M | ||
| Assets Non-Current | 2.15M | ||
| Total Debt (USD) | 14.95M | ||
| Goodwill and Intangible Assets | 1.84M | ||
| Liabilities Non-Current | 7.46M | ||
| Trade and Non-Trade Payables | 606.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 58.00K | ||
| Net Cash Flow from Financing | 168.46M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 19.88M | ||
| Capital Expenditure | -16.00K | ||
| Issuance (Purchase) of Equity Shares | 168.46M | ||
| Net Cash Flow from Investing | -137.80M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -137.62M | ||
| Net Cash Flow from Operations | -10.78M | ||
| Effect of Exchange Rate Changes on Cash | 3.00K | ||
| Share Based Compensation | 6.96M | ||